University of Toronto, Toronto, ON, Canada. Background: In our institution HER2 status is assessed on all newly diagnosed breast cancers. HER2 FISH is performed on cases equivocal by immunohistochemistry (4B5 and SP3 clones). Dual in situ hybridization (DISH), an alternative to FISH, has ...